|
Match
|
Document |
Document Title |
|
|
6652840 |
Bleeding control and healing aid compositions and methods of use
A composition is disclosed which has been shown to stop or control bleeding and seal open small blood vessels while accelerating the healing process of abraded oral “gum” and other “skin”...
|
|
|
6645523 |
Paroxetine compositions and processes for making the same
Paroxetine salt compositions having improved stability are formed by controlling the pH to 6.5 or less. The compositions can be made with the aide of water without significant coloration problems....
|
|
|
6638534 |
Preparation capable of releasing drug at target site in intestine
A preparation capable of releasing a medicinal substance at a targeted site in the intestine, wherein the preparation dose not releases medicinal substance in endogastri at all, but can quickly...
|
|
|
6638532 |
Tetracycline—doxycycline antibiotic composition
An antibiotic product for delivering at least Tetracycline or Doxycycline that is comprised of three dosage forms with different release profiles with each of Tetracycline and Doxycycline being...
|
|
|
6635277 |
Composition for pulsatile delivery of diltiazem and process of manufacture
A once-a-day controlled release drug delivery system of diltiazem hydrochloride is provided, which is bioequivalent in plasma profile of Cardizem CD. The fast, medium, and slow release fractions...
|
|
|
6630162 |
Pharmaceutical formulation and its use
The invention relates to a pharmaceutical formulation containing tolterodine or a tolterodine-related compound, or a pharmacologically acceptable salt thereof, as active ingredient, in which the...
|
|
|
6627222 |
Amoxicillin-dicloxacillin antibiotic composition
An antibiotic product for delivering at least Amoxicillin or dicloxacillin that is comprised of three dosage forms with different release profiles with each of Amoxicillin and dicloxacillin being...
|
|
|
6623755 |
Pharmaceutical tablets
The present invention relates to novel pharmaceutical tablets useful for administering pharmaceutical active ingredients, such as bisphosphonates. These tablets have improved surface properties...
|
|
|
6617305 |
Stable aqueous dispersion of nutrients
This invention relates to a stable aqueous dispersion of nutrients and more particularly, to an aqueous dispersions of an active nutritional ingredient selected form (a) an isoflavone, (b) lycopene...
|
|
|
6610328 |
Amoxicillin-clarithromycin antibiotic composition
An antibiotic product for delivering at least Amoxicillin or Clarithromycin that is comprised of three dosage forms with different release profiles with each of Amoxicillin and Clarithromycin being...
|
|
|
6610327 |
Pharmaceutical moxifloxacin preparation
The present invention relates to a pharmaceutical preparation for oral administration which comprises moxifloxacin, its salt and/or hydrate and lactose, to a process for its preparation, and to the...
|
|
|
6607747 |
High drug load acid labile pharmaceutical composition
A high drug load spheronized beadlet is provided wherein said beadlet comprises about 80% to 100% by weight of an acid labile medicament, preferably didanosine, about 0% to about 10% by weight of a...
|
|
|
6605303 |
Oral pharmaceutical extended release dosage form
An enteric coated pharmaceutical extended release dosage form of a H + , K + -ATPase inhibitor giving an extended plasma concentration profile of a H + , K + -ATPase inhibitor. The extended plasma...
|
|
|
6599531 |
Method of making ibuprofen and narcotic analgesic compositions
Provided herein are compositions and methods of making compositions of ibuprofen in combination with a narcotic analgesic. Specifically provided is a pharmaceutical tablet composition comprising...
|
|
|
6599535 |
Pharmaceutical compositions
A pharmaceutical composition in the form of a solid dispersion comprising a macrolide, e.g. a rapamycin or an ascomycin, and a carrier medium.
|
|
|
6596297 |
Biodegradable microbicidal vaginal barrier device
An intravaginal bio-erodible microbicidal barrier device. The device comprises (a) at least one micronized compound selected from the group consisting of cellulose acetate phthalate and...
|
|
|
6589563 |
Drug delivery system exhibiting permeability control
Microparticles and nanoparticles prepared from oppositely charged polymers are provided in which a drug is incorporated into the core and is conjugated to one polymer by a Schiff-base crosslink....
|
|
|
6586012 |
Taste masked pharmaceutical liquid formulations
A liquid composition for oral administration comprising a pharmaceutically active medicament coated with a taste masking effective amount of a polymer blend of (a) dimethylaminoethyl methacrylate...
|
|
|
6576258 |
Pharmaceutical formulation with controlled release of active substances
There is disclosed a method for stabilizing active substances that are unstable in acidic medium, unstable when stored for longer periods of time in the presence of water and at the same time...
|
|
|
6572898 |
Electrolyte gels for maintaining hydration and rehydration
A gel rehydration electrolyte composition provides a convenient and effective way of replenishing lost fluid and electrolytes. The gel rehydration electrolyte composition masks unpleasant tastes of...
|
|
|
6569466 |
Conditioning of bioactive glass surfaces in protein containing solutions
Conditioning of the surface of silica-based glass or ceramic by differential immersion in a serum protein-containing solution, and the resultant microporous Ca-P surface layer having serum-protein...
|
|
|
6569462 |
Layering process for multiparticulate dosage form
The present invention relates to a new layering process, in particular to a process for the manufacture of multiparticulate solid oral dosage forms based on a dry spray layering technique...
|
|
|
6555581 |
Levothyroxine compositions and methods
The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized...
|
|
|
6548170 |
Treated water-insoluble solid particles, preparation and use
The present invention relates to water-insoluble solid particles, especially pigments, which characteristically are coated with at least one layer of at least one product resulting from the...
|
|
|
6531160 |
Microcapsules with an aqueous core containing at least one water-soluble cosmetic or dermatological active principle and cosmetic or dermatological compositions containing them
The present invention relates to microcapsules with an aqueous core containing at least one water-soluble cosmetic or dermatological active principle, and with a polymeric and/or waxy envelope, in...
|
|
|
6524620 |
Diltiazem controlled release formulation and method of manufacture
A controlled release diltiazem dosage formulation comprising a plurality of active pellets coated with an extended release coating wherein the active pellets contain diltiazem or a pharmaceutically...
|
|
|
6500455 |
Tolperison-containing, pharmaceutical preparation for oral administration
A pharmaceutical preparation containing Tolperison or a salt thereof as an active ingredient in the form of a racemic mixture which can be a 50/50/-racemat or a racemat with the perponderant...
|
|
|
6500462 |
Edible MCC/PGA coating composition
An edible, hardenable coating composition is disclosed containing microcrystalline cellulose, a film forming amount of propylene glycol alginate, and a strengthening polymer, optionally in...
|
|
|
6495163 |
Moisture barrier film coating composition, method and coated form
A dry moisture barrier film coating composition for forming a moisture barrier film coating for pharmaceutical tablets and the like comprises polyvinyl alcohol, soya lecithin, and optionally a flow...
|
|
|
6488964 |
Process for manufacturing coated gabapentin or pregabalin particles
A process for manufacturing coated particles of γ-aminobutyric acid analogue, whose lactam content by weight relative to the weight of γ-aminobutyric acid analogue is less than 0.5% is disclosed....
|
|
|
6479075 |
Pharmaceutical formulations for acid labile substances
This invention in general relates to novel pharmaceutical compositions for acid labile substances as well as for methods of making such. Specifically, the invention provides a pharmaceutical...
|
|
|
6458389 |
Microgranules containing cisplatin
The invention concerns an oral formulation of cisplatin, in the form of controlled-release microgranules, and its method of formulation by grossing in an aqueous medium. The invention also concerns...
|
|
|
6451345 |
Functional coating of linezolid microcapsules for taste-masking and associated formulation for oral administration
The present invention provides taste-masked microcapsules of Linezolid or the like (any member of the orally effective oxazolidinone or macrolide antibiotics), suitable for oral administration as a...
|
|
|
6451327 |
Skin cleansing composition
The invention relates to a substantially nonaqueous skin cleansing composition comprising a granulated product obtained by granulating particles of a surfactant selected from the group consisting...
|
|
|
6451350 |
Controlled release tramadol preparation with a storage-stable release profile and process for their production
A process for producing an oral, controlled release preparation of tramadol or a physiologically compatible tramadol salt having a storage stable active substance release profile by coating the...
|
|
|
6447807 |
Potassium (-)-hydroxycitric acid methods for pharmaceutical preparations for stable and controlled delivery
A method for making the potassium and sodium salts of (−)-hydroxycitric acid and mixtures thereof workable, non-hygroscopic and non-reactive in acidic media by encasement in hydrophobic and...
|
|
|
6436438 |
Tramadol multiple unit formulations
A multiple unit oral pharmaceutical dosage form having a plurality of pellets in a water soluble capsule or in a tablet compressed from the pellets, wherein each pellet contains (a) a substantially...
|
|
|
6428805 |
Powdery nasal compositions
A powdery nasal composition comprising a drug and colloidal cellulose is provided. The composition is a nasal composition providing a superior absorption activity for the drug.
|
|
|
6429296 |
Complex of human growth hormone and zinc and use
The present invention provides a complex of human growth hormone and zinc containing human growth hormone and zinc at a molar ratio of about 1:1.6 to about 1:2.4, and a sustained-release...
|
|
|
6416752 |
Termite bait composition and method
An improved termite bait composition comprises a powdered cellulosic attractant having a particle size in the range of approximately 1 to 100 micrometers and a termite killing agent. Also disclosed...
|
|
|
6379706 |
Rapidly disintegrating coated pellets with delayed release
The invention concerns pharmaceutical forms of administration that are in the form of pellets which contain a retarding agent in which the release rate of the active substance is not delayed or is...
|
|
|
6368628 |
Sustained release pharmaceutical composition free of food effect
The invention provides a sustained release composition free of food effect comprising a core comprising an active agent except for carbamazepine or verapamil, and a coating comprising, based on the...
|
|
|
6365182 |
Organoleptically pleasant in-mouth rapidly disintegrable potassium chloride tablet
The present invention relates to a potassium containing dosage form which is capable of rapidly disintegrating in a patient's mouth to form an easy to swallow slurry.
|
|
|
6348216 |
Ibuprofen and narcotic analgesic compositions
Provided herein are compositions and methods of making compositions of ibuprofen in combination with a narcotic analgesic. Specifically provided is a pharmaceutical tablet composition comprising...
|
|
|
6342245 |
Compositions of lipid lowering agents
The present invention is concerned with novel pharmaceutical compositions of lipid lowering agents which can be administered to a mammal suffering from hyperlipidemia, obesitas or atherosclerosis,...
|
|
|
6326027 |
Controlled release formulation
A controlled release preparation for oral administration contains tramadol, or a pharmaceutically acceptable salt thereof, as active ingredient.
|
|
|
6312728 |
Sustained release pharmaceutical preparation
The present invention pertains to a sustained release drug delivery system which comprises a core of active ingredient, an enteric coating, a second coating of active ingredient and lastly a...
|
|
|
6309666 |
Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract
A pharmaceutical preparation in the form of a coated capsule which can release contents of a capsule at a lower part of the digestive tract comprising (a) a hard capsule containing at least an...
|
|
|
6306900 |
Enteric coated pharmaceutical compositions
This invention provides a pharmaceutical composition comprising a mycophenolate salt, the composition being adapted to release mycophenolate in the upper part of the intestinal tract.
|
|
|
6299903 |
Delayed release pharmaceutical formulation containing a β-lactam antibiotic
Pharmaceutical formulations for oral administration, comprising a matrix which comprises a β-lactam antibiotic, a β-lactamase inhibitor, and granules in a delayed release form dispersed within...
|